Tag: Presents

Posted on

Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with … – MarketWatch (press release)

Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with …
MarketWatch (press release)
Boehringer Ingelheim announced that a comprehensive confirmatory Phase III trial program named UniTinA-asthma(TM) is ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma in pediatric, adolescent and adult …
Boehringer Ingelheim Announces Positive Phase II Results for Once-Daily …EON: Enhanced Online News (press release)
Results of Phase II Study of Boehringer Ingelheim's Investigational …Sacramento Bee

all 23 news articles »

View full post on asthma – Google News

Posted on

World Allergy Congress Presents Scientific Advancements in Allergy, Asthma … – PR Web (press release)


PR Web (press release)

World Allergy Congress Presents Scientific Advancements in Allergy, Asthma …
PR Web (press release)
Allergic diseases and asthma are increasing worldwide, affecting as much as 30% of the world's population. New research and international expert consensus recommendations will be presented that will impact on the future management of these globally …

and more »

View full post on asthma – Google News

Posted on

Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American … – MarketWatch (press release)

Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American …
MarketWatch (press release)
5, during the American College of Allergy, Asthma and Immunology annual meeting in Boston. "In addition to a reduced rate of serious bacterial infections, the phase III study data suggest potentially useful attributes of HyQ, such as the possibility …

and more »

View full post on asthma – Google News

Posted on

Teva Presents New Data on QNASL(TM) at the 2011 American College of Allergy … – MarketWatch (press release)

Teva Presents New Data on QNASL(TM) at the 2011 American College of Allergy …
MarketWatch (press release)
In addition, the presence of co-morbidities such as asthma and sinusitis further increase AR-related treatment costs. QNASL(TM) is an investigational intranasal corticosteroid in development for the treatment of allergic rhinitis symptoms. …
Teva Presents New Data On QNASL™ At The 2011 American College Of Allergy …TheStreet.com (press release)

all 13 news articles »

View full post on asthma – Google News

Posted on

EU Marie Curie scientist presents new evidence of ‘asthma gene’ in children – IEWY News

EU Marie Curie scientist presents new evidence of 'asthma gene' in children
IEWY News
A scientist supported by the European Union's Marie Curie research fund has found new evidence that a specific 'asthma gene' is a cause of the respiratory condition in children. The young German scientist, Michaela Schedel, believes that her findings …

View full post on asthma – Google News

Posted on

Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze(TM … – MarketWatch (press release)

Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze(TM …
MarketWatch (press release)
Currently available adenosine agonists must be used with caution or are contraindicated in patients with asthma and COPD. The findings, presented at the …
Clinical Data Reveals Positive Results From Early-stage Trials Of Stedivaze …Stock Markets Review

all 13 news articles »

View full post on asthma – Google News